114.39
price up icon0.09%   0.10
after-market Handel nachbörslich: 114.36 -0.03 -0.03%
loading

Finanzdaten der Arcellx Inc-Aktie (ACLX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
66.58%
1.654
4.949 7.554 8.129 26.03
Operating Expenses
2.08%
65.34
66.72 66.28 77.03 59.65
Benefits Costs and Expenses
1.65%
59.73
60.73 60.30 70.40 51.67
Costs And Expenses
1.65%
59.73
60.73 60.30 70.40 51.67
Operating Income/Loss
3.09%
-63.68
-61.78 -58.73 -68.90 -33.62
Income/Loss From Continuing Operations Before Tax
4.11%
-58.07
-55.78 -52.74 -62.27 -25.64
Income Tax Expense/Benefit
0.04
- 0.029 - 0.223
Income/Loss From Continuing Operations After Tax
4.18%
-58.11
-55.78 -52.77 -62.27 -25.87
Net Income/Loss
4.18%
-58.11
-55.78 -52.77 -62.27 -25.87
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.07%
0.5274
56.59 56.22 55.26 53.82
Diluted Average Shares
99.07%
0.5274
56.59 56.22 55.26 53.82
Basic Earnings Per Share
2.02%
-1.01
-0.99 -0.94 -1.13 -0.48
Diluted Earnings Per Share
2.02%
-1.01
-0.99 -0.94 -1.13 -0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):